Background: Patients with immune-mediated diseases such as rheumatoid arthritis, psoriatic arthritis, or inflammatory bowel disease (IBD) are increasingly being prescribed biologics. While biologics may account for roughly 2% of total prescriptions in the United States, they account for over 35% of net drug spending and for over 80% of the growth in net drug spending.1,2 [...]